High-dose oral pyrophosphate inhibits connective tissue calcification in Abcc6 null mice but affects bone structure.
Ontology highlight
ABSTRACT: Pseudoxanthoma elasticum is a rare inherited disorder marked by abnormal calcium phosphate deposition in soft connective tissues, particularly the skin, arteries, and eyes. It is caused by inactivating mutations in the ABCC6 gene, which encodes a hepatic efflux transporter. Loss of ABCC6 function leads to reduced plasma levels of pyrophosphate, a key inhibitor of calcification, thereby promoting ectopic mineralization. Oral pyrophosphate therapy has emerged as a potential treatment, but its effectiveness is uncertain. Most ingested pyrophosphate is hydrolyzed in the gut to inorganic phosphate, which may worsen calcification. Moreover, its impact on mineralized tissues remains largely unexplored. Abcc6-/- mice closely mimic human pseudoxanthoma elasticum and are widely
SUBMITTER: Rajpar I
PROVIDER: S-EPMC12330526 | biostudies-literature | 2025 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA